Volpara Health Technologies Ltd

Healthcare AU VHT


Last update at 2024-05-22T00:00:00Z

Day Range


52 Week Range



Income Statement


Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2023-03-31 2022-03-31 2021-03-31 2020-03-31 2019-03-31
Type yearly yearly yearly yearly yearly
Date 2023-03-31 2022-03-31 2021-03-31 2020-03-31 2019-03-31
Income before tax -10.65244M -15.01441M -17.39558M -21.71395M -11.25551M
Minority interest - - - - -
Net income -9.17439M -15.28116M -16.05435M -19.82549M -11.24401M
Selling general administrative 12.45M 11.39M 11.51M 11.59M 2.92M
Selling and marketing expenses 14.29M 13.12M 11.28M 12.92M 8.08M
Gross profit 30.30M 22.14M 16.57M 10.59M 3.95M
Reconciled depreciation 5.13M 4.33M 2.84M 2.18M 0.30M
Ebit -10.29767M -14.88057M -17.26154M -21.64181M -11.19900M
Ebitda -5.16522M -10.55024M -14.42578M -19.45793M -10.90213M
Depreciation and amortization 5.13M 4.33M 2.84M 2.18M 0.30M
Non operating income net other - - - - -
Operating income -10.29767M -14.88057M -17.26154M -21.64181M -12.74756M
Other operating expenses 50.89M 46.63M 40.19M 39.05M 17.54M
Interest expense 0.35M 0.13M 0.13M 0.07M 0.06M
Tax provision -1.47805M 0.27M -1.34123M -1.93700M -0.01200M
Interest income 0.17M 0.16M 0.57M 0.70M 0.41M
Net interest income -0.18066M 0.03M 0.44M 0.68M 0.39M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense -1.47805M 0.27M -1.34123M -1.88847M -0.01149M
Total revenue 32.77M 24.27M 18.13M 12.32M 4.79M
Total operating expenses 48.42M 44.50M 38.63M 37.32M 16.70M
Cost of revenue 2.47M 2.13M 1.55M 1.73M 0.84M
Total other income expense net -0.35477M -0.13384M -0.13403M -0.07215M 1.49M
Discontinued operations - - - - -
Net income from continuing ops -9.17439M -15.28116M -16.05435M -19.86058M -11.24401M
Net income applicable to common shares -9.80100M -16.44100M -17.48800M -20.37100M -11.74100M
Preferred stock and other adjustments - - - - -
Breakdown 2023-03-31 2022-03-31 2021-03-31 2020-03-31 2019-03-31
Type yearly yearly yearly yearly yearly
Date 2023-03-31 2022-03-31 2021-03-31 2020-03-31 2019-03-31
Total assets 74.15M 75.27M 86.86M 71.10M 18.17M
Intangible assets 23.44M 23.85M 24.94M 17.56M 0.34M
Earning assets - - - - -
Other current assets 1.00M 0.66M 0.41M 0.38M 0.39M
Total liab 26.18M 21.47M 20.03M 20.19M 4.59M
Total stockholder equity 47.97M 53.81M 66.83M 50.91M 13.58M
Deferred long term liab - 2.33M 1.75M 1.59M 0.93M
Other current liab 4.31M 3.79M 2.68M 3.59M 1.73M
Common stock 171.55M 168.69M 165.87M 136.57M 80.57M
Capital stock 171.55M 168.69M 165.87M 136.57M 80.57M
Retained earnings -127.04577M -117.38730M -101.03461M -90.21449M -69.15150M
Other liab - 0.29M 1.14M 1.64M 0.02M
Good will 20.21M 17.96M 17.68M 8.02M -
Other assets 3.84M 2.42M 1.83M 1.59M 0.94M
Cash 11.90M 16.86M 29.59M 30.59M 13.77M
Cash and equivalents - - 2.00M 0.00000M 1.75M
Total current liabilities 24.74M 19.43M 16.32M 15.51M 4.45M
Current deferred revenue 18.91M 13.91M 10.50M 10.46M 2.07M
Net debt -9.95132M -14.56083M -24.65437M -26.92210M -13.53285M
Short term debt 0.51M 0.53M 2.27M 0.59M 0.12M
Short long term debt - - 1.83M - 0.12M
Short long term debt total 1.95M 2.30M 4.93M 3.67M 0.24M
Other stockholder equity 0.00000M 2.69M 2.18M -0.03510M 0.00000M
Property plant equipment 2.28M 2.79M 3.41M 4.55M 0.55M
Total current assets 24.39M 28.29M 39.43M 39.53M 16.40M
Long term investments 0.38M 0.33M - - -
Net tangible assets - 12.90M 26.37M 25.99M 13.83M
Short term investments 5.40M 0.28M 24.36M 27.70M 10.27M
Net receivables 10.23M 8.80M 7.91M 7.35M 2.20M
Long term debt - 0.00000M 0.45M - 0.13M
Inventory 1.27M 1.69M 0.05M 0.05M 0.03M
Accounts payable 1.01M 1.19M 0.87M 0.86M 0.52M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income 3.47M 2.50M 2.00M 4.59M 2.17M
Additional paid in capital - - - - -
Common stock total equity - - 165.87M 136.57M 80.57M
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other 2.88M 2.17M 1.61M 1.55M 0.90M
Deferred long term asset charges - - - - -
Non current assets total 49.75M 46.98M 47.43M 31.56M 1.77M
Capital lease obligations 1.95M 2.30M 2.66M 3.67M 0.24M
Long term debt total 1.53M 1.91M 2.90M 3.16M 0.13M
Breakdown 2023-03-31 2022-03-31 2021-03-31 2020-03-31 2019-03-31
Type yearly yearly yearly yearly yearly
Date 2023-03-31 2022-03-31 2021-03-31 2020-03-31 2019-03-31
Investments 2.75M 15.50M 2.35M -16.59900M -8.76900M
Change to liabilities 0.00000M 3.79M 0.85M 6.61M 2.01M
Total cashflows from investing activities 2.94M 13.20M -23.10500M -39.31500M -9.46300M
Net borrowings - -0.53600M 2.22M -0.29000M -0.08700M
Total cash from financing activities 0.50M -0.02324M 38.44M 53.85M 19.82M
Change to operating activities - -0.83800M -0.50600M -0.60300M -0.62600M
Net income -9.17439M -15.28116M -16.05435M -19.82549M -11.24401M
Change in cash 0.03M 1.68M 3.86M -0.42800M 0.74M
Begin period cash flow 9.06M 7.32M 3.37M 4.01M 3.20M
End period cash flow 9.09M 8.99M 7.23M 3.58M 3.94M
Total cash from operating activities -9.17439M 4.33M -12.87157M -15.55816M -10.64200M
Issuance of capital stock 1.05M 0.47M 37.86M 57.18M 20.84M
Depreciation 2.86M 4.33M 2.84M 2.18M 0.30M
Other cashflows from investing activities 5.51M 15.37M -22.27800M -38.98600M -8.76900M
Dividends paid - - - - -
Change to inventory - - 0.00200M -0.01400M -0.01800M
Change to account receivables - -0.48100M -1.34200M -2.96500M -1.09100M
Sale purchase of stock 1.12M 0.51M -1.46975M -3.04377M -0.93852M
Other cashflows from financing activities -0.55134M -0.49819M 2.04M -0.28273M -0.08332M
Change to netincome - -2.04500M 1.38M -1.53100M 0.51M
Capital expenditures 2.40M 2.02M 0.76M 0.98M 0.66M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital 0.47M 0.37M 1.57M 1.40M 1.04M
Stock based compensation - - - - -
Other non cash items 9.17M 10.95M 13.22M 17.68M 10.95M
Free cash flow -11.57821M 2.31M -13.63077M -16.54187M -10.85616M


  • Previous Close 1.15
  • Market Cap291.26M
  • Volume0
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-7.89700M
  • Revenue TTM37.96M
  • Revenue Per Share TTM0.15
  • Gross Profit TTM 23.82M
  • Diluted EPS TTM-0.04

Peer Comparison

Sector: Healthcare Industry: Health Information Services

Company Change (AUD) Price (AUD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
Volpara Health Technologies Ltd
- -% 1.15 - - 7.65 6.53 7.78 -60.9831
Pro Medicus Ltd
1.45 1.28% 114.69 172.97 113.64 78.98 70.50 78.09 106.71
Medadvisor Ltd
0.01 2.33% 0.44 - 25.97 1.29 2.56 1.22 -108.7944
Oneview Healthcare PLC
-0.015 4.92% 0.29 - - 26.22 16.80 25.10 -29.9289
CogState Ltd
-0.02 1.60% 1.23 24.60 32.79 5.22 3.67 4.24 22.21

Reports Covered

Stock Research & News


Volpara Health Technologies Limited provides breast imaging analytics software products in New Zealand. The company offers Volpara Analytics, a software that optimize breast cancer screening operations; Volpara Live, which provides instant patient-based image quality feedback; Volpara Lung, a patient management software that streamlines lung screening workflow; and Volpara Patient Hub, a customizable mammography reporting and patient communications software. It also offers Volpara Risk, an integration with Patient Hub that uses TC8 to calculate patients' risk of developing breast cancer; Volpara Risk Pathways, a program for identifying and managing high-risk breast, lung, ovarian, and colorectal cancer screening patients; Volpara Scorecard, which displays patient breast density and risk insights essential for improved clinical decision-making and early detection; and Volpara Science, an AI-based software that powers Volpara software products; and Volpara Thumbnail, an image-enhanced patient notification letters. In addition, the company provides TruDensity, a Volpara clinical function; TruPGMI, a Volpara clinical function, which uses artificial intelligence to automatically and objectively assess the positioning of the patient and resulting image quality; TruPressure, a Volpara clinical function, which determines whether the compression pressure applied by the radiographer is in the sweet spot that yields quality images, minimal radiation exposure, and the least discomfort; and TruRadDose, a Volpara clinical function which analyses the radiation dose delivered to patients based on their breast density. It operates in North America, the Asia Pacific, Europe, the Middle East, and Africa. Volpara Health Technologies Limited has a strategic relationship with RevealDx. The company was incorporated in 2009 and is headquartered in Wellington, New Zealand.

Volpara Health Technologies Ltd

40 Mercer Street, Wellington, New Zealand, 6011

Key Executives

Name Title Year Born
Dr. Ralph P. Highnam B.Sc., M.Sc., Ph.D. Founder, MD, Chief Scientist & Chief Science and Innotion Officer NA
Mr. Craig Hadfield CFO & Company Sec. NA
Ms. Teri Thomas CEO, MD & Director NA
Prof. Nico Karssemeijer Co-Founder & Member of Scientific Board NA
Mr. Tana Isaac Exec. VP of Product & Technology NA
Mr. Gareth Beaumont Chief Information Officer & Chief Information Security Officer NA
Mr. Fred Struve B.Sc., J.D. Joint Company Sec. & Gen. Counsel NA
Ms. Jill Spear Exec. VP of Sales & Marketing NA
Ms. Kathryn Greene Chief People Officer NA
Mr. Julian Marshall Chief Knowledge Officer NA

Disclaimer - Data Powered by EOD Historical Data (“EODHD”). All CFDs (stocks, indices, mutual funds, ETFs), and Forex are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. EODHD is not using exchanges data feeds for the pricing data, EODHD is using OTC, peer to peer trades and trading platforms over 100+ sources, EODHD is aggregating its data feeds via VWAP method. Therefore, EOD Historical Data doesn’t bear any responsibility for any trading losses you might incur as a result of using this data. EOD Historical Data or anyone involved with EOD Historical Data will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible. EOD Historical Data does not give any warranties (including, without limitation, as to merchantability or fitness for a particular purpose or use).